Pathomics Health, a diagnostics and research service provider, focuses on advanced precision diagnostics and digital healthcare solutions. Its full-service CAP (College of American Pathologists) –compliant laboratory deploys cutting-edge technologies that are clinically validated by international bodies such as FDA and CE-IVD. Equipped with a multi-disciplinary team of experts, Pathomics Health’s customers and patients receive high-quality diagnostics reports for better management of patient care and health outcomes. In 2017, the University of Malaya and Pathomics Health established GEMS@UM, a public-private partnership, to provide patients access to cost-effective precision medicine. In 2019, Pathomics Health established its regional headquarters in Singapore. In 2022, Pathomics Health is expanding its laboratory operations from Malaysia to Singapore.
Pathomics Health and MAHSA Health sign MOU to launch Joint Centre for Research and Diagnostics for Precision Wellness and Clinical Research
KUALA LUMPUR, MALAYSIA –
